Additional file 2: of Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
- Yahya Ashraf (2278519)
- Hanane Mansouri (6296147)
- Valérie Laurent-Matha (6296150)
- Lindsay Alcaraz (6296153)
- Pascal Roger (2333854)
- Séverine Guiu (3603593)
- Danielle Derocq (230988)
- Gautier Robin (80691)
- Henri-Alexandre Michaud (247573)
- Helène Delpech (6296156)
- Marta Jarlier (438685)
- Martine Pugnière (57241)
- Bruno Robert (86929)
- Anthony Puel (6296159)
- Lucie Martin (6296162)
- Flavie Landomiel (6296165)
- Thomas Bourquard (352815)
- Oussama Achour (6296168)
- Ingrid Fruitier-Arnaudin (2551495)
- Alexandre Pichard (753509)
- Emmanuel Deshayes (6296174)
- Andrei Turtoi (457036)
- Anne Poupon (138761)
- Joëlle Simony-Lafontaine (6296183)
- Florence Boissière-Michot (6296186)
- Nelly Pirot (256703)
- Florence Bernex (61689)
- William Jacot (3422492)
- Stanislas Manoir (6296189)
- Charles Theillet (6296192)
- Jean-Pierre Pouget (438693)
- Isabelle Navarro-Teulon (438692)
- Nathalie Bonnefoy (134104)
- André Pèlegrin (5648674)
- Thierry Chardès (6296195)
- Pierre Martineau (6238)
- Emmanuelle Liaudet-Coopman (231007)
Publication date
February 2019
DOIAbstract
Figure S1. Cath-D expression in different BC subtypes. Total cath-D expression was determined in 159 whole cytosols from primary BC biopsies (HR+/HER2+ (n = 38); HR-/HER2+ (n = 38); HR+/HER2- (n = 42); HR-/HER- (n = 41)) by sandwich ELISA with the immobilized anti-human cath-D D7E3 antibody and the anti-human cath-D M1G8 antibody coupled to HRP. HR= ER + PR. Mean ± SEM. (PPTX 61 kb
Add to ORKG